Profile
Robert Lutz is currently an Executive-in-Residence at ShangPharma Innovation, Inc. He was previously a VP-Translational Research & Development at ImmunoGen, Inc. from 1992 to 2015.
He received a doctorate degree from Brandeis University in 1987 and an undergraduate degree from the University of New Hampshire in 1981.
Robert Lutz active positions
| Companies | Position | Start |
|---|---|---|
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Consultant / Advisor | - |
Former positions of Robert Lutz
| Companies | Position | End |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01/04/2015 |
Training of Robert Lutz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Robert Lutz
















